Brazil was already set to test the COVID-19 vaccine from China.
Brazil will start its advanced clinical testing of a COVID-19 vaccine from China on Tuesday, according to Brazilian officials.
This, as officials said that Brazil was issuing the first doses of the said vaccine to around 900 volunteers.
The said vaccine — which was developed by Sinovac — was the third vaccine to enter its Phase 3 trials in the world, or large-scale testing on humans.
Named as “CoronaVac”, it would be applied to doctors and other health workers who volunteered for the said program across Brazil’s six states.
Joao Doria, the state’s governor, told a news conference that trials of CoronaVac would start at the Clinical Hospital of Sao Paulo, adding that the initial results were expected to arrive within 90 days.
- OPPO Philippines Gives Smartphones, Earphones To Save the Children
- Galaxy Unpacked 2020: Samsung Teases New Galaxy Fold
- Clint Bondad To Media: ‘Do Your Research’
Sinovac was partnering with the Butantan Institute — a public health research center in Brazil — on the said trials.
According to Brazilian officials, the Butantan institute would have the right to produce 120 million doses of CoronaVac under the deal with Sinovac if the said vaccine was proven effective and safe.
Dimas Covas, the head of the Butantan Institute, said that they could have the “first vaccine” to be put into widespread use in Brazil.
Brazil was currently the second-hardest-hit country in the pandemic as its death toll reached over 80,000 on Monday, and it has reported 2.1 million infections.
What can you say about this? Let us know in the comments below!